Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months. (Q53905756)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

title

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

main subject

Lyme disease

0 references

author name string

Schoen RT

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Sikand VK

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Caldwell MC

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Van Hoecke C

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Gillet M

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Buscarino C

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

Parenti DL

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

publication date

1 March 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

published in

Clinical Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

volume

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

page(s)

315-325

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

cites work

Underreporting of Lyme disease by Connecticut physicians, 1992

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The public health impact of Lyme disease in Maryland

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980035-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0149-2918(00)80035-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

PubMed publication ID

10963286

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10963286

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10963286

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53905756&oldid=1613929351"